Aethon Therapeutics reposted this
We are delighted to announce Christoph Rader, CTO at Aethon Therapeutics, will be speaking at the 4th Edition of The Antibody Series (Sept 4 - 6, 2024) on "Creating and targeting synthetic neoepitopes on cancer cells". 💡 Discover Christoph Rader's biography and abstract here: https://lnkd.in/euJzgCyc 🎫 Pre-register free for on-demand access to this talk and more: https://lnkd.in/eNd2cBKp 🌎 THE ANTIBODY SERIES (TAS) is the fastest growing antibody event of its kind. TAS brings together industry and academia experts in-person to exchange innovative ideas in antibody discovery and development co-joined by +4,000 registered antibody members online. #neoepitopes #research #antibody #conference #speaker #tas24
Chief Technology Officer, Aethon Therapeutics, Inc.
7moLooking forward to it. Thank you Paul Parren for the invitation.